Referenslitteratur för:

Cimicifuga racemosa och Remifemin med speciell hänsyn till leverpåverkan
 
  FÖRFATTARE OCH TIDSKRIFT
PUBLICERAD
HÄMTA PDF
       
  1. Svenska Läkemedelsverket. Preparat: Remifemin tabletter. Angående Remifemin och leverbiverkningar.
Dnr: 94-4046; MTnr: 149440.

 2006 Hämta här
  2. Hope J.
HRT alternatives "could damage your health" warning from Royal College of Obstetrics and Gynecology, London.
RCOG September 1, 2006.

2006 Hämta här
  3. Australian Government, Department of Health and Ageing.
Black cohosh (Cimicifuga racemosa): New labelling and consumer information for medicines containing Black cohosh (Cimicifuga racemosa).
Therapeutic Goods Administration, February 9, 2006.

2006 Hämta här
  4. European Medicines Agency, Evulation of Medicines for Human Use:
Committee on Herbal Medicinal Products (HMPC):
Assessment of case reports connected to herbal medicinal products containing Cimicifugae Racimosae Rhizoma (Black Cohosh, Root)

2006 Hämta här
  5. European Medicines Agency, Press Office:
EMEA publoc statement on herbal medicinal products containing Cimicifugae Racemosae Rhizoma (Black Cohosh, root) - serious hepatic reactions.
Doc. Ref.: EMEA/269259/2006.

2006 Hämta här
  6. Medicines and Healthcare products Regulatory Agency (MHRA):
MHRA action on safety concerns over Black Cohosh and liver injury.
Press release 18th July 2006.

2006 Hämta här
  7. Lüde S.
Hepatotoxicity of the Phytomedicines Kava Kava and Cimicifuga Racemosa.
Inauguraldissertation.
Zürich (ZH) and Château d'Oex (VD), Olten, 2005.

2005 Hämta här
  8. National Center for Complementary and Alternative Medicine. NIH Office of Dietary Supplements.
Workshop on the Safety of Black Cohosh in Clinical Studies.
National Institutes of Health, Bethesda, MD, November 2004.

2004
 Hämta här
  9. Whiting PW, Clouston A, Kerlin P.
Black cohosh and other herbal remedies associated with acute hepatitis.
MJA, 2002: 177; 432 - 435.



 2002 Hämta här